Treatment of Breakthrough Pain

Previous | Next

Breakthrough pain is a common problem for many patients, so additional opioid doses should be prescribed on an as-needed basis. These additional opioid doses should be approximately one half of the regular four-hour opioid dose, or about 10% of the 24-hour dose. For patients on opioid infusions, the breakthrough dose is usually 50% to 100% of the hourly infusion rate. Regular use of additional doses (more than three to four times daily) may signal the need to increase the baseline dose or the need for an adjuvant analgesic.

The information below describes three types of breakthrough pain and strategies for treatment.

Type: Incident

Characteristics:

  • Activity-related

  • Has identifiable precipitant

  • Usually nociceptive

Solution:

  • Anticipate and pre-medicate with short-acting agent

Type: Idiopathic or Spontaneous

Characteristics:

  • Unpredictable

  • Usually neuropathic visceral

Solution:

  • Add adjuvant medication

Type: End-of-dose Failure

Characteristics:

  • Predictable return of pain before next scheduled dose of medication

Solution:

  • Increase dose or shorten the time between dose of the long-acting agent (e.g., every eight hours instead of every 12 hours)

Previous | Next